Inconsistency in circulating irisin levels: What is really happening?

Hormone and Metabolic Research

Volumn 46, Issue 8, 2014, Pages 591-596

  Sanchis Gomar, F ^a   Alis, R ^b   Pareja Galeano, H ^a   Romagnoli, M ^b   Perez Quilis, C ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

Author keywords

diabetes; hormone; metabolic syndrome; myokine; obesity

Indexed keywords

FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

BLOOD; DIABETES MELLITUS; EXERCISE; HUMAN; OBESITY;

DIABETES MELLITUS; EXERCISE; FIBRONECTINS; HUMANS; OBESITY;

EID: 84904471519     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1363283     Document Type: Review

References (33)

1. Bostrom P., Wu J., Jedrychowski M. P., Korde A., Ye L., Lo J. C., Rasbach K. A., Bostrom E. A., Choi J. H., Long J. Z., Kajimura S., Zingaretti M. C., Vind B. F., Tu H., Cinti S., Hojlund K., Gygi S. P., Spiegelman B. M. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature: 2012; 481 463 468
2. Spiegelman B. M. Banting lecture 2012: regulation of adipogenesis: toward new therapeutics for metabolic disease. Diabetes: 2013; 62 1774 1782
3. Pedersen B. K., Febbraio M. A. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol: 2012; 8 457 465
4. Bostrom P. A., Graham E. L., Georgiadi A., Ma X. Impact of exercise on muscle and nonmuscle organs. IUBMB Life: 2013; 65 845 850
5. Wrann C. D., White J. P., Salogiannnis J., Laznik-Bogoslavski D., Wu J., Ma D., Lin J. D., Greenberg M. E., Spiegelman B. M. Exercise Induces Hippocampal BDNF through a PGC-1alpha/FNDC5 Pathway. Cell Metab: 2013; 18 649 659
6. Polyzos S. A., Kountouras J., Shields K., Mantzoros C. S. Irisin: a renaissance in metabolism? Metabolism: 2013; 62 1037 1044
7. Elbelt U., Hofmann T., Stengel A. Irisin: what promise does it hold? Curr Opin Clin Nutr Metab Care: 2013; 16 541 547
8. Villarroya F. Irisin, turning up the heat. Cell Metab: 2013; 15 277 278
9. Sanchis-Gomar F., Lippi G., Mayero S., Perez-Quilis C., Garcia-Gimenez J. L. Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes. J Diabetes: 2012; 4 196
10. Sanchis-Gomar F. The skeletal muscle-metabolism axis in prostate-cancer therapy. N Engl J Med: 2013; 367 2257 2258
11. Cunha A. Basic research: Irisin - behind the benefits of exercise. Nat Rev Endocrinol: 2012; 8 195
12. Enerback S. Adipose tissue metabolism in 2012: Adipose tissue plasticity and new therapeutic targets. Nat Rev Endocrinol: 2013; 9 69 70
13. Sanchis-Gomar F., Perez-Quilis C. Irisinemia: A Novel Concept to Coin in Clinical Medicine? Ann Nutr Metab: 2013; 63 60 61
14. Huh J. Y., Panagiotou G., Mougios V., Brinkoetter M., Vamvini M. T., Schneider B. E., Mantzoros C. S. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism: 2012; 61 1725 1738
15. Stengel A., Hofmann T., Goebel-Stengel M., Elbelt U., Kobelt P., Klapp B. F. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity - Correlation with body mass index. Peptides: 2013; 39 125 130
16. Moreno-Navarrete J. M., Ortega F., Serrano M., Guerra E., Pardo G., Tinahones F., Ricart W., Manuel-Fernandez-Real J. Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance. J Clin Endocrinol Metab: 2013; 98 E769 E778
17. Choi Y. K., Kim M. K., Bae K. H., Seo H. A., Jeong J. Y., Lee W. K., Kim J. G., Lee I. K., Park K. G. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract: 2013; 100 96 101
18. Liu J. J., Wong M. D., Toy W. C., Tan C. S., Liu S., Ng X. W., Tavintharan S., Sum C. F., Lim S. C. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complicat: 2013; 27 365 369
19. Park K. H., Zaichenko L., Brinkoetter M., Thakkar B., Sahin-Efe A., Joung K. E., Tsoukas M. A., Geladari E. V., Huh J. Y., Dincer F., Davis C. R., Crowell J. A., Mantzoros C. S. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab: 2013; 98 4899 4907
20. Vamvini M. T., Aronis K. N., Panagiotou G., Huh J. Y., Chamberland J. P., Brinkoetter M. T., Petrou M., Christophi C. A., Kales S. N., Christiani D. C., Mantzoros C. S. Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans. Eur J Endocrinol: 2013; 169 829 834
21. Polyzos S. A., Kountouras J., Anastasilakis A. D., Geladari E. V., Mantzoros C. S. Irisin in patients with nonalcoholic fatty liver disease. Metabolism: 2013; S0026-0495(13)00297-7
22. Zhang H. J., Zhang X. F., Ma Z. M., Pan L. L., Chen Z., Han H. W., Han C. K., Zhuang X. J., Lu Y., Li X. J., Yang S. Y., Li X. Y. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J Hepatol: 2013; 59 557 562
23. Pekkala S., Wiklund P., Hulmi J. J., Ahtiainen J. P., Horttanainen M., Pollanen E., Makela K. A., Kainulainen H., Hakkinen K., Nyman K., Alen M., Herzig K. H., Cheng S. Are Skeletal Muscle FNDC5 Gene Expression and Irisin Release Regulated by Exercise and Related to Health? J Physiol: 2013; 591 5393 5400
24. Moraes C., Leal V. O., Marinho S. M., Barroso S. G., Rocha G. S., Boaventura G. T., Mafra D. Resistance Exercise Training does not Affect Plasma Irisin Levels of Hemodialysis Patients. Horm Metab Res: 2013; 45 900 904
25. Norheim F., Langleite T. M., Hjorth M., Holen T., Kielland A., Stadheim H. K., Gulseth H. L., Birkeland K. I., Jensen J., Drevon C. A. The effects of acute and chronic exercise on PGC-1alpha, irisin and browning of subcutaneous adipose tissue in human. FEBS J: 2013; 10.1111/febs.12619 [epub ahead of print]
26. Hecksteden A., Wegmann M., Steffen A., Kraushaar J., Morsch A., Ruppenthal S., Kaestner L., Meyer T. Irisin and exercise training in humans - Results from a randomized controlled training trial. BMC Med: 2013; 11 235
27. Raschke S., Elsen M., Gassenhuber H., Sommerfeld M., Schwahn U., Brockmann B., Jung R., Wisloff U., Tjonna A. E., Raastad T., Hallen J., Norheim F., Drevon C. A., Romacho T., Eckardt K., Eckel J. Evidence against a Beneficial Effect of Irisin in Humans. PLoS One: 2013; 8 e73680
28. Kraemer R. R., Shockett P., Webb N. D., Shah U., Castracane V. D. A Transient Elevated Irisin Blood Concentration in Response to Prolonged, Moderate Aerobic Exercise in Young Men and Women. Horm Metab Res: 2013; 10.1055/s-0033-1355381 [epub ahead of print]
29. Aydin S., Kuloglu T., Yilmaz M., Kalayci M., Sahin I., Cicek D. Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45min of a Turkish bath or running. Peptides: 2013; 50C 13 18
30. Hojlund K., Bostrom P. Irisin in obesity and type 2 diabetes. J Diabetes Complications: 2013; 27 303 304
31. Timmons J. A., Baar K., Davidsen P. K., Atherton P. J. Is irisin a human exercise gene? Nature: 2012; 488 E9 E10 discussion E10-E11
32. Erickson H. P. Irisin and FNDC5 in retrospect: An exercise hormone or a transmembrane receptor? Adipocyte: 2013; 2 289 293
33. Schumacher M. A., Chinnam N., Ohashi T., Shah R. S., Erickson H. Structure of irisin reveals a novel intersubunit beta-sheet fibronectin (FNIII) dimer; implications for receptor activation. J Biol Chem: 2013; 288 33738 33744